BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26375716)

  • 21. Prevention of Rh alloimmunization.
    Fung Kee Fung K; Eason E; Crane J; Armson A; De La Ronde S; Farine D; Keenan-Lindsay L; Leduc L; Reid GJ; Aerde JV; Wilson RD; Davies G; Désilets VA; Summers A; Wyatt P; Young DC;
    J Obstet Gynaecol Can; 2003 Sep; 25(9):765-73. PubMed ID: 12970812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management and Follow-up of Massive Fetomaternal Hemorrhage Requiring High-Dose Rh Immune Globulin: A Case Report.
    Fortes PA; Gnass ED; Baez J; Bayati B; Mei Z; McGonigle AM; Ziman A; Ward DC
    Am J Clin Pathol; 2023 Jul; 160(1):78-80. PubMed ID: 36897771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postpartum Rh immunoprophylaxis.
    Sandler SG; Gottschall JL
    Obstet Gynecol; 2012 Dec; 120(6):1428-38. PubMed ID: 23168770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fetal-maternal bleed in the second trimester of pregnancy. A report of two cases.
    Gass ML; Carey PM
    J Reprod Med; 1992 Apr; 37(4):378-80. PubMed ID: 1317453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection and quantitation of fetomaternal hemorrhage.
    Turner WA; Fadel HE; Krauss JS
    South Med J; 1986 May; 79(5):571-5. PubMed ID: 3010476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laboratory methods for Rh immunoprophylaxis: a review.
    Sandler SG; Sathiyamoorthy S
    Immunohematology; 2010; 26(3):92-103. PubMed ID: 21214295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Case of Massive Fetal-Maternal Hemorrhage: Lessons Learned in Diagnosis and Treatment.
    Raymond C; Grant B; Zahner C
    Lab Med; 2023 May; 54(3):333-336. PubMed ID: 36315004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fetomaternal hemorrhage following trauma.
    Rose PG; Strohm PL; Zuspan FP
    Am J Obstet Gynecol; 1985 Dec; 153(8):844-7. PubMed ID: 3934978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The incidence of significant fetomaternal hemorrhage in patients undergoing cesarean section.
    Feldman N; Skoll A; Sibai B
    Am J Obstet Gynecol; 1990 Sep; 163(3):855-8. PubMed ID: 2169706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-D administration after spontaneous miscarriage for preventing Rhesus alloimmunisation.
    Karanth L; Jaafar SH; Kanagasabai S; Nair NS; Barua A
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009617. PubMed ID: 23543581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistent fetal hemoglobin in maternal circulation complicating the diagnosis of fetomaternal hemorrhage.
    Kush ML; Muench MV; Harman CR; Baschat AA
    Obstet Gynecol; 2005 Apr; 105(4):872-4. PubMed ID: 15802419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of Rh immune globulin: a review.
    Sutton GP; Jay A; Lim YS; Noland JE; Boral LI
    Indiana Med; 1988 Apr; 81(4):321-2. PubMed ID: 2834434
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of quantitative acid-elution technique and flow cytometry for detecting fetomaternal hemorrhage.
    Corsetti JP; Cox C; Leary JF; Cox MT; Blumberg N; Doherty RA
    Ann Clin Lab Sci; 1987; 17(3):197-206. PubMed ID: 3111343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A combined flow cytometry-based method for fetomaternal hemorrhage and maternal D.
    Radel DJ; Penz CS; Dietz AB; Gastineau DA
    Transfusion; 2008 Sep; 48(9):1886-91. PubMed ID: 18513253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-D administration in pregnancy for preventing Rhesus alloimmunisation.
    Crowther CA; Middleton P; McBain RD
    Cochrane Database Syst Rev; 2013 Feb; (2):CD000020. PubMed ID: 23450526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Guideline for prevention of RhD alloimmunizationin RhD negative women].
    Lubušký M; Procházka M; Simetka O; Holusková I
    Ceska Gynekol; 2013 Apr; 78(2):132-3. PubMed ID: 23710977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inaccurate doses of R immune globulin after rh-incompatible fetomaternal hemorrhage: survey of laboratory practice.
    Ramsey G;
    Arch Pathol Lab Med; 2009 Mar; 133(3):465-9. PubMed ID: 19260751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ante-partum administration of preventive treatment of Rh-D immunization in rhesus-negative women. Parallel evaluation of transplacental passage of fetal blood cells. Results of a multicenter study carried out in the Paris region].
    Huchet J; Dallemagne S; Huchet C; Brossard Y; Larsen M; Parnet-Mathieu F
    J Gynecol Obstet Biol Reprod (Paris); 1987; 16(1):101-11. PubMed ID: 3035003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kleihauer-betke testing is important in all cases of maternal trauma.
    Muench MV; Baschat AA; Reddy UM; Mighty HE; Weiner CP; Scalea TM; Harman CR
    J Trauma; 2004 Nov; 57(5):1094-8. PubMed ID: 15580038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two cases of asymptomatic massive fetomaternal hemorrhage.
    Peedin AR; Mazepa MA; Park YA; Weimer ET; Schmitz JL; Raval JS
    Transfus Apher Sci; 2015 Apr; 52(2):208-10. PubMed ID: 25736586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.